As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Pooled data from six large cohorts show near dose-response effect, extending previous stud ...

Researchers analyzed data from 1,903 patients with stage 3 or stage 4 epithelial ovarian cancer who were enrolled in four ...

For many people, spotting blood in the urine is often the first warning sign of bladder cancer. But for those with color ...

Elenagen plus gemcitabine improves overall survival in platinum resistant ovarian cancer without increasing toxicity in Phase ...

Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima ...

Louisiana governor Jeff Landry spent much of last year demonizing the pharmacy giant CVS, columnist Quin Hillyer says. Suddenly, he’s singing its praises. What changed?

Gen-Z and Millennial women are rethinking motherhood because the world they're navigating looks very different from the one their parents inherited. Here are five key factors influencing how younger ...

I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me,” writes Erica Rex, author of the new book “Seeing ...

ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe ...

A drug designed to help cancer patients rebuild wasting muscles has become one of the most contentious substances in elite ...

ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries -- Dublin-based subsidiary to support ImmunityBio's distribution and ...